top of page
Oral Polio Vaccine – Bivalent (Type 1 and Type 3)

Generic Name:

Oral Polio Vaccine – Bivalent (Type 1 and Type 3)



The live attenuated strains of the poliomyelitis types 1 and 3 (Sabin strain) viruses are suspended in the oral polio vaccine bivalent. Each dose contains at least 106.0 CCID50 of the type 1 strain of the virus and 105.8 CCID50 of the type 3 strain of the virus. As a stabilizer, this vaccine comprises one mole of magnesium chloride (MgCl2), along with the antibiotics Kanamycin Acid Sulphate and Neomycin Sulphate. The vaccine complies with WHO criteria for Types 1 & 3 Bivalent Poliomyelitis Vaccine (Oral).




Each dose of vaccine contains:










Pharmaceutical Form:

Liquid Vaccine (Oral suspension)


Method of Administration:

This vaccine is administered Orally. Two drops  from the multi-dose vial are delivered directly into the mouth by a dropper or dispenser.



2 drops of 0.1 ml.



10 dose Vial and 20 dose Vial


Possible Side Effects:

No side effects observed



Immunodeficiency - People with HIV infection, whether they are symptomatic or asymptomatic, should receive the vaccination in accordance with the recommended schedule. A primary immunodeficiency condition or a medication-induced suppression of the immune system, such as leukemia, lymphoma, or generalized malignancy, are contraindications to receiving the vaccine.


Shelf Life:

24 months



Until the expiration date printed on the vial, it is advised to store this vaccine at a temperature of -20°C or lower. But at any point throughout the shelf life, the vaccine can be stored between +2°C and +8°C.

WhatsApp Image 2023-01-10 at 10.31.28 AM.jpeg
bottom of page